There are two types of aplastic anemia: congenital and acquired. The acquired form represents over 90% of cases and usually results from an autoimmune attack against hematopoietic stem cells. The most common clinical manifestations reflect the low blood counts and include dyspnea on exertion, fatigue...
Anemia is the most common hematologic disorder in patients with ulcerative colitis (UC). In some cases, normochromic anemia results from the presence of chronic disease; however blood loss or malabsorption may lead to an iron deficiency anemia with hypochromic appearance. Other rare hematologic manif...
In contrast toaplastic anemia, leukemia results in a highly cellular marrow. 与再生障碍性贫血不同, 白血病的结果是骨髓有大量细胞. 互联网 Chemical factors were the most common reason for secondaryaplastic anemia. 化学因素是继发性再障最常见的病因. ...
Background: Severe Aplastic Anemia (SAA) is a rare bone marrow disorder characterized by inadequate levels of peripheral, multi-lineage blood cells. Of the two available first-line treatments for SAA, allogeneic hematopoietic stem cell transplantation is limited by patient eligibility and donor availabi...
aplastic anemia- anemia characterized by pancytopenia resulting from failure of the bone marrow; can be caused by neoplasm or by toxic exposure aplastic anaemia anemia,anaemia- a deficiency of red blood cells Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farl...
Immunosuppressive therapy (IST) is the first choice for severe aplastic anemia (SAA) patients with hematopoietic stem cell transplantation (HSCT) limitation, and the main factor limiting its efficacy is too few residual hematopoietic stem/progenitor cells (HSPC). Eltrombopag (EPAG), as a small molec...
Aplastic anemia (AA) is characterized by pancytopenia and bone marrow hypoplasia, which results from immune-mediated hematopoiesis suppression. Understanding the pathophysiology of the immune system, particularly T cells immunity, has led to improved AA treatment over the past decades. However, primary ...
Severe aplastic anemia (SAA) is characterized by trilineage marrow hypoplasia and a paucity of hematopoietic stem cell (HSC) progenitors. SAA is treated with immunosuppressive therapy (IST) or allogeneic HSC transplantation (HSCT), with a successful outcome after either treatment in a majority of pa...
Aplastic Anemia From a Vaccine First, always get medical attention as soon as possible. Then, contact a vaccine injury lawyer who can effectively represent you in the Federal Vaccine Court. If your aplastic anemia was triggered by a vaccine, you could be eligible for compensation for your vaccin...
Aplastic anemia (AA) is characterized by pancytopenia and bone marrow hypoplasia, which results from immune-mediated hematopoiesis suppression. Understanding the pathophysiology of the immune system, particularly T cells immunity, has led to improved AA treatment over the past decades. However, primary ...